US 11952376
Substituted amino acids as integrin inhibitors
granted A61PA61P1/16A61P11/00
Quick answer
US patent 11952376 (Substituted amino acids as integrin inhibitors) held by Pliant Therapeutics, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pliant Therapeutics, Inc.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 172
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00